A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
收藏Mendeley Data2024-01-31 更新2024-06-28 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006057/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study evaluating the efficacy and safety of lampalizumab administered by intravitreal injections in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
创建时间：
2024-01-31
